Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Muzahir H. Tayebjee, Sunil Nadar, Andrew D. Blann, D. Gareth Beevers, Robert J. MacFadyen, Gregory Y H Lip

Research output: Contribution to journalArticlepeer-review

116 Citations (Scopus)

Fingerprint Dive into the research topics of 'Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)'. Together they form a unique fingerprint.

Medicine & Life Sciences